FDA outlines criteria for conducting long-term neurodevelopmental safety studies in neonates
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesClinical TrialsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesClinical TrialsMedical DevicesNorth AmericaPharmaceuticalsProduct Lifecycle